Harrow (HROW) Interest Expenses (2010 - 2026)
Harrow's (HROW) quarterly Interest Expenses came in at $15.7 million in Q1 2026, down 68.2% year-on-year from $49.5 million in Q1 2025, and down 32.57% quarter-over-quarter from $23.3 million in Q4 2025.
Harrow (HROW) Interest Expenses (2010 - 2026) Analysis & Trends
Harrow's Interest Expenses history runs 17 years deep, the most recent figure standing at $15.7 million for Q1 2026.
- On a quarterly basis, Interest Expenses fell 68.2% year-over-year to $15.7 million in Q1 2026; TTM through Mar 2026 was $15.7 million, a 68.2% decrease from a year earlier, with the FY2025 full-year figure at $64.1 million, down 4.41% from the prior year.
- Interest Expenses retreated to $15.7 million in Q1 2026 per HROW's latest filing, from $23.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $95.8 million in Q3 2024 and bottomed at -$4.5 million in Q4 2022.
- The 5-year median for Interest Expenses is $19.9 million (2022), against an average of $24.2 million.
- Across the five-year window, Interest Expenses tumbled 300.95% in 2022 and soared 813.92% in 2025, its largest moves.
- Year by year, Interest Expenses stood at -$4.5 million in 2022, then jumped by 557.36% to $20.4 million in 2023, then tumbled by 64.55% to $7.2 million in 2024, then jumped by 222.69% to $23.3 million in 2025, then slumped by 32.57% to $15.7 million in 2026.
- Per Business Quant, the three latest HROW Interest Expenses figures stand at $15.7 million (Q1 2026), $23.3 million (Q4 2025), and $907000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | 15.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.74 Mn |
| Mar 31, 2026 | 15.74 Mn |
| Dec 31, 2025 | 23.34 Mn |
| Dec 31, 2025 | 23.34 Mn |
| Sep 30, 2025 | 907,000.00 |
| Sep 30, 2025 | 907,000.00 |
| Jun 30, 2025 | 58.68 Mn |
| Jun 30, 2025 | 58.68 Mn |
| Mar 31, 2025 | 49.49 Mn |
| Mar 31, 2025 | 49.49 Mn |
| Dec 31, 2024 | 7.23 Mn |
| Dec 31, 2024 | 7.23 Mn |
| Sep 30, 2024 | 95.81 Mn |
| Sep 30, 2024 | 95.81 Mn |
| Jun 30, 2024 | 39.02 Mn |
| Jun 30, 2024 | 39.02 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Dec 31, 2023 | 20.40 Mn |
| Dec 31, 2023 | 20.40 Mn |